AstraZeneca PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other pharmaceutical manufacturers in Europe: Novo Nordisk As of DENMARK (2019 sales of 122.02 billion Danish Kroner [US$17.92 billion] of which 84% was Diabetes and obesity), Lonza Group AG of SWITZERLAND (5.92 billion Swiss Francs [US$6.13 billion] ), and Merck KGaA which is based in GERMANY (16.15 billion Euros [US$17.71 billion] of which 42% was Life Science).

Sales Analysis. During the year ended December of 2019, sales at AstraZeneca PLC were £19.06 billion (US$23.59 billion). This is an increase of 14.8% versus 2018, when the company's sales were £16.60 billion.